Monoclonal Antibodies for Treatment of COVID-19: An Updated Review of Current Evidence

The emergence of COVID-19 in December 2019 spurred a global effort to develop effective medical interventions. Therapeutic monoclonal antibodies (mAbs) have emerged as a promising strategy to combat the SARS-CoV-2 virus. Several mAbs targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spi...

Full description

Saved in:
Bibliographic Details
Main Authors: Saurabh Nimesh, Pratibha Kumari, Rohit Kumar, Gosiya Gosiya, Md. Quamuddin, Md. Iftekhar Ahmad
Format: Article
Language:English
Published: Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya 2024-11-01
Series:Borneo Journal of Pharmacy
Subjects:
Online Access:https://journal.umpr.ac.id/index.php/bjop/article/view/6365
Tags: Add Tag
No Tags, Be the first to tag this record!